Increased risk of depression and anxiety when in higher education
Young people who are in higher education in England face a small increased risk of depression and anxiety, compared to their peers who are not attending higher education,… read more.
Young people who are in higher education in England face a small increased risk of depression and anxiety, compared to their peers who are not attending higher education,… read more.
When Kylie Jenner famously admitted that her signature pout was the result of lip fillers, there was a significant increase in interest and uptake of the cosmetic procedure. That’s… read more.
While life expectancy rates for older Americans are rising, nearly 40% of adults report living with a digestive disease of some kind. “Many people don’t realize that these… read more.
Co-users of tobacco and cannabis report more anxiety and depression than users of tobacco only and users of neither substance. Researchers reported these findings in PLOS ONE on… read more.
Simple home workouts using exercise apps can effectively reduce depressive symptoms in healthcare workers and could be a major tool to combat the global mental health crisis in… read more.
A new blood test called p-tau217 shows promise as an Alzheimer’s disease biomarker, and when used in a two-step workflow very high accuracy to either identify or exclude… read more.
For roughly 80% of breast cancer survivors, treatment doesn’t end with surgery, radiation and chemotherapy. Instead, for the next five to 10 years, doctors recommend that they take… read more.
“We find that people who are in better shape fill fewer prescriptions for anxiety and depression medications,” says Linda Ernstsen, the senior author of the article and an… read more.
Research from Saint Louis University School of Medicine finds that among patients 65 and older, a diagnosis of anxiety was significantly associated with an increased risk of dementia… read more.
Sage Therapeutics, Inc .and Biogen Inc. announced the FDA approved Zurzuvae (zuranolone) 50 mg for adults with postpartum depression (PPD). Zurzuvae is the first and only oral, once-daily,… read more.
More than half of patients with auto-immune conditions experience mental health conditions such as depression or anxiety, yet the majority are rarely or never asked in clinic about… read more.
A new talking therapy for depression has shown encouraging early signs of being more effective and cheaper to deliver than the current best practice of Cognitive Behavioural Therapy… read more.